Prot #CDX110-04: An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The "ACT IV" Study)

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/11/12 → 5/11/18

Funding

  • Novella Clinical, LLC (Prot #CDX110-04 // Prot #CDX110-04)
  • Celldex Therapeutics, Inc. (Prot #CDX110-04 // Prot #CDX110-04)